Drug Trial Radar · NCT06912633
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
31
Actual
Start
Jun 20, 2025
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- jCyte, IncIndustry
- Sponsor type
- Industry
- First posted
- Apr 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the safety of a single injection of jCell (famzeretcel) comprising 6.0 million (6.0M) retinal progenitor cells over a six-month study period in a cohort of adult subjects with RP. Additionally, changes in visual function will be evaluated at six months between the active treatment group (6.0M jCell) compared to sham-treated controls.
Conditions
- Retinitis Pigmentosa
Interventions
human retinal progenitor cellsBiological
Single intravitreal injection of 6.0 million retinal progenitor cells (RPCs)
Mock injectionOther
Pressing the hub of a syringe with no needle against the eye to mimic intravitreal injection. Subjects randomized to the sham control group will undergo identical preparation as the active treatment group immediately prior to treatment, including application of anesthetics.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of Intravitreal Injection of 6.0M jCellTime frame: 6 months
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Associated Retina Consultants
Phoenix, Arizona
California Retina Consultants
Bakersfield, California
Retina-Vitreous Associates Medical Group
Beverly Hills, California
Gavin Herbert Eye Institute, UC Irvine
Irvine, California
Retina Consultants Medical Group
Sacramento, California
Vitreo Retinal Associates
Gainesville, Florida
Illinois Retina Associates
Oak Park, Illinois
NJRetina
Teaneck, New Jersey
Long Island Vitreoretinal Consultants
Westbury, New York
Retina Consultants of Texas: Bellaire Retina Center
Bellaire, Texas
Retina Consultants of Texas: San Antonio
San Antonio, Texas
The Retina Group of Washington
Fairfax, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.